These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33648910)

  • 41. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
    Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Daylight Photodynamic Therapy: What is Known and What is Yet to be Determined.
    Fitzmaurice S; Eisen DB
    Dermatol Surg; 2016 Mar; 42(3):286-95. PubMed ID: 26918967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
    Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    Morton CA
    J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy in dermatology: a review.
    Choudhary S; Nouri K; Elsaie ML
    Lasers Med Sci; 2009 Nov; 24(6):971-80. PubMed ID: 19653060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The application of physical pretreatment in photodynamic therapy for skin diseases.
    Liu D; Zhao S; Li J; Chen M; Wu L
    Lasers Med Sci; 2021 Sep; 36(7):1369-1377. PubMed ID: 33404884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
    Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
    Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Realizing the cosmetic potential of topical photodynamic therapy.
    Morton CA
    J Cosmet Dermatol; 2002 Jul; 1(2):66-71. PubMed ID: 17147522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
    Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
    Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
    Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daylight-mediated photodynamic therapy in Spain: advantages and disadvantages.
    Pérez-Pérez L; García-Gavín J; Gilaberte Y
    Actas Dermosifiliogr; 2014 Sep; 105(7):663-74. PubMed ID: 24726043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
    Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
    Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daylight photodynamic therapy for the treatment of actinic cheilitis.
    Levi A; Hodak E; Enk CD; Snast I; Slodownik D; Lapidoth M
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):11-16. PubMed ID: 30066408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.
    Fayter D; Corbett M; Heirs M; Fox D; Eastwood A
    Health Technol Assess; 2010 Jul; 14(37):1-288. PubMed ID: 20663420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
    Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
    Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.
    Varma S; Wilson H; Kurwa HA; Gambles B; Charman C; Pearse AD; Taylor D; Anstey AV
    Br J Dermatol; 2001 Mar; 144(3):567-74. PubMed ID: 11260016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.